Investors Ride Dendreon and 4 Other Earnings Rollercoaster Rides

Dendreon Corp. (NASDAQ:DNDN) had a loss and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share decreased to $-0.45 in the quarter versus EPS of $-0.65 in the year-earlier quarter. Revenue Decreased 8.38% to $73.29 million from the year-earlier quarter.

Dendreon Corp. reported adjusted EPS loss of $0.45 per share. By that measure, the company missed the mean analyst estimate of $-0.42. It missed the average revenue estimate of $75.61 million.

DNDN 20130811

Medivation, Inc. (NASDAQ:MDVN) had a loss and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share increased to $-0.07 in the quarter versus EPS of $-0.08 in the year-earlier quarter. Revenue Rose 63.48% to $70.15 million from the year-earlier quarter.

Medivation, Inc. reported adjusted EPS loss of $0.07 per share. By that measure, the company beat the mean analyst estimate of $-0.21. It beat the average revenue estimate of $59.35 million.

MDVN 20130811

Onyx Pharmaceuticals Inc. (NASDAQ:ONXX) had a loss and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share decreased to $-0.4 in the quarter versus EPS of $-0.68 in the year-earlier quarter. Revenue Rose 110.5% to $153.03 million from the year-earlier quarter.

Onyx Pharmaceuticals Inc. reported adjusted EPS loss of $0.4 per share. By that measure, the company beat the mean analyst estimate of $-0.42. It beat the average revenue estimate of $151.73 million.

ONXX 20130811

Impax Laboratories Inc. (NASDAQ:IPXL) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share decreased 61.67% to $0.23 in the quarter versus EPS of $0.60 in the year-earlier quarter. Revenue Decreased 22.14% to $129.6 million from the year-earlier quarter.

Impax Laboratories Inc. reported adjusted EPS income of $0.23 per share. By that measure, the company beat the mean analyst estimate of $0.04. It beat the average revenue estimate of $120.75 million.

IPXL 20130811

Air Methods Corp. (NASDAQ:AIRM) delivered a profit and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share decreased 35.8% to $0.52 in the quarter versus EPS of $0.81 in the year-earlier quarter. Revenue Rose 1.67% to $226.2 million from the year-earlier quarter.

Air Methods Corp. reported adjusted EPS income of $0.52 per share. By that measure, the company missed the mean analyst estimate of $0.6. It missed the average revenue estimate of $227.71 million.

AIRM 20130811

Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.

More from The Cheat Sheet